Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Opioids
Pharma
FDA signs off on Vertex's non-opioid pain reliever Journavx
Vertex has gained an FDA approval for Journavx, a nonaddictive oral treatment which is the first innovation in pain relief in more than two decades.
Kevin Dunleavy
Jan 30, 2025 9:22pm
Vertex survey delves into current difficulties in pain treatment
Oct 10, 2024 10:25am
Purdue Pharma snags nod for new overdose-reversal injection
Aug 9, 2024 9:35am
BMJ report digs into Mallinckrodt's opioid selling tactics
Jun 10, 2024 6:30pm
Mallinckrodt wins court go-ahead for 2nd bankruptcy
Oct 11, 2023 10:55am
Emergent launches OTC overdose drug so 'anyone can save a life'
Aug 31, 2023 9:55am